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Abstract
Background: The Cancer Genome Atlas (TCGA) is a pool of molecular data sets publicly accessible and freely
available to cancer researchers anywhere around the world. However, wide spread use is limited since an advanced
knowledge of statistics and statistical software is required.
Results: In order to improve accessibility we created Web-TCGA, a web based, freely accessible online tool, which
can also be run in a private instance, for integrated analysis of molecular cancer data sets provided by TCGA. In
contrast to already available tools, Web-TCGA utilizes different methods for analysis and visualization of TCGA data,
allowing users to generate global molecular profiles across different cancer entities simultaneously. In addition to
global molecular profiles, Web-TCGA offers highly detailed gene and tumor entity centric analysis by providing
interactive tables and views.
Conclusions: As a supplement to other already available tools, such as cBioPortal (Sci Signal 6:pl1, 2013, Cancer Discov
2:401–4, 2012), Web-TCGA is offering an analysis service, which does not require any installation or configuration, for
molecular data sets available at the TCGA. Individual processing requests (queries) are generated by the user for
mutation, methylation, expression and copy number variation (CNV) analyses. The user can focus analyses on results
from single genes and cancer entities or perform a global analysis (multiple cancer entities and genes simultaneously).
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Background
With the ongoing decrease of cost for next generation
sequencing and other high throughput molecular
characterization methods, a vast amount of data sets are
generated and provided for public access on web portals.
In the field of cancer research, The Cancer Genome
Atlas (TCGA) [1] data portal is the largest and most
commonly used public resource, providing somatic
mutation, gene expression, gene methylation and copy
number variation (CNV) data sets, amongst others, for
several thousands of tumor samples. Even though TCGA
is a powerful and well-organized repository of molecular
data types, the mining of its data is still limited. This is due
to the fact that many tools (e.g. Excel or SPSS) commonly
used by researchers outside the field of bioinformatics, are
not capable of handling this vast amount of data. More-
over, the data sets provided often require preprocessing or
further analysis, which may require advanced expertise in
computational biology and computer programming. Other
available tools, such as the cBioPortal, TCGA-Assembler
[2] or Firebrowse (http://firebrowse.org/) show limitations
when comparing multiple studies or require programming
skills. Indeed cBioPortal can handle multiple studies at the
same time, but is not able to incorporate them into a sin-
gle analysis and does not provide any methylation ana-
lyses, while both modes are available with Web-TCGA.
Further, TCGA-Assember does not include any graphical
interface, which is an integral part of Web-TCGA. In
addition, Firebrowse is only capable of displaying pre-
calculated results, while Web-TCGA uses these data for
further statistics and visualization., Therefore Web-TCGA
is a fast and flexible web based software, which provides
an infrastructure for comprehensive analyzing and visual-
izing the most common data types provided by TCGA.
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Web-TCGA is freely available and accessible to everyone
and can also be run as a standalone application on every
computer having the R programming language installed
(see private instance below).
Implementation
Data integration
The data available at the TCGA is provided by the Fire-
hose Pipeline of the Broad Institute [1] and was directly
downloaded from this archive using the firehose_get
script [3]. The data of the test instance is imported from
the Firehose pipeline as of September 2014 and will be
updated on a regular basis.
Data processing
Within TCGA the data are provided on different levels,
ranging from one to three, each indicating an increasing
state of pre-processing and data aggregation. On level
one only raw-data is provided, while level two is charac-
terized by basic pre-processing or filtering, which de-
pends on the data type (see below). Level three data are
only available if segmented and interpreted results can
be provided for that data type.
To keep the amount of data as small as possible and to
reduce preprocessing and calculation time, Web-TCGA
includes the highest data level available for each type.
Web-TCGA directly makes use of somatic mutation data
(level 2) and somatic CNV data (level 4, GISTIC2.0 output
[4]), which do not require any further processing. For
methylation and gene expression profiling, level 3 data is
imported and processed as described below. For gene
expression status two different preprocessing methods are
available, namely RNA-SeqV1 (Reads Per Kilobase per
Million, RPKM) and RNA-SeqV2 (RNA-Seq by Expect-
ation Maximization, RSEM). We decided to use RNA-
SeqV2, which takes transcript length into account and is
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Fig. 1 Illustration of mutational data. a Provides an overview of the global mutational profile of TP53, TSHZ3 and VHL highlighting the cancer
entity specific occurrence of mutations within BRCA and KIRC, while TSHZ3, as control, remains undetected. In b and c, the mutational profile is
broken down into the type of predicted impact on the protein sequences. The slice size denotes the proportion of a mutation type in relation to
all mutations. The given percentage denotes the proportion of a mutation type in relation to all tumor samples of a given entity
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suggested to provide more accurate results [5] for down-
stream analysis. Here, gene expression profiles are calcu-
lated using RSEM data. Due to the lack of normal
samples, the relative expression for a specific gene is cal-
culated by Web-TCGA using its expression status in a
tumor sample of a given entity, compared to its average
expression status in the remaining samples of the same
entity [6]. For comparison one can choose whether to use
the z-score or the fold change as basis for calculation. The
z-score is defined as number of standard deviations above
or below the mean of the gene's expression levels in the
reference cohort.
For methylation data, we incorporated two modes of
analysis into Web-TCGA. The first considers paired
tumor/normal samples only, the second takes all sam-
ples of an entity into account. Within each mode a
paired/unpaired Wilcoxon test is followed by a
Benjamini-Hochberg p-value correction [7] to estimate
differential methylation levels, as introduced by Hinoue
et al. [8]. A p-value correction is necessary to correct
for multiple hypothesis testing. Besides these test statis-
tics, one can quantify the difference between tumor and
control methylation values, which allows the user to es-
timate if a complete gene or parts of a gene is hyper- or
hypomethylated. This second type of calculation is con-
sidered when rendering graphics, since p-values are not
correlated with the direction of differential methylation.
Private instance
For running a private instance, the source code can be
downloaded from github (see paragraph Availability and























































Fig. 2 Illustration of methylation data. Different to all other analyses types for methylation data the global view is just provided for one cancer
entity at a time, due to the fact that the gene is partitioned into different regions. a Provides a global profile of the methylation status in SFRP1
and SFRP4 in COAD, where SFRP1s is highly differential methylated in its body region and SFRP4, as control, remains mostly unmethylated. Further, b
and c give an estimate of the differential methylation distribution, which also allows the detection of shifts. The x-axis shows difference of the ß-values
of the methylation status between tumor and normal samples. The y-axis reflects the number of samples
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using firehose_get by the user. Further it is possible to ob-
tain the data using third party applications (such as TCGA-
Assembler) as long as the TCGA default format is main-
tained. Afterwards the data is integrated using fully auto-
mated R scripts provided in the pre-process_data folder
and becomes available after restarting the application.
Results and Discussion
The Web-TCGA user interface
Web-TCGA is semantically divided into a left and
right hand work space. While the left one is used for
user input only, the right one is used for navigation
and output (see Additional file 1: Figure S1). In the
right workspace, the red highlighted navigation bar is
used to choose the type of data to analyze and sup-
plies additional information about the methods used.
Within each element of the navigation bar an add-
itional navigation bar (highlighted in purple) is dis-
played for choosing the analysis method. This bar is
specific to each data type. Below this second naviga-
tion bar, the yellow highlighted field is reserved for
graphical output. In the left workspace, the user is
supplied with the input menus (highlighted green),
which are semantically divided by the type of input
(highlighted dark blue).
Visualization of global mutation profiling
As proof of principle, we created global mutation
profiles of several well-known cancer entity-specific
alterations using Web-TGCA. For somatic mutation
profiling, we tested TP53 known to be associated with
breast invasive carcinoma (TCGA abbreviation BRCA)
but not kidney renal clear cell cancer (KIRC), VHL
being associated with KIRC, but not BRCA, and
TSHZ3 shown to be absent in both entities. For
BRCA, 992 samples from TCGA and for KIRC, 437
samples were included into our analysis. Figure 1a
shows the visualization of the global mutation profile in
Web-TCGA (including the cancer entities and genes se-
lected by the user) of TP53, VHL and TSHZ3 for these
to tumor entities. As expected, the overall mutation
rate for TP53 is much higher in BRCA (33.1 %) than in
KIRC (1.8 %), vice versa for VHL and extremely low for
TSHZ3 in both entities. To further illustrate the muta-
tion frequency of these genes, we incorporated circle
charts for a more detailed view (Fig. 1b and c). Here,
the mutation frequencies of these three genes within
each cancer entity are depicted, divided into the per-
centage of non-sense mutations, missense mutations,
frame-shift deletions and insertions and splice sites al-
terations. Generally, all variant classes provided by the
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Fig. 3 Illustration of expression data. To examine the global expression profile, the genes expression status in multiple cancer entities is rendered
in the same way, as in Fig. 1a. Further, a waterfall plot, as shown in (a), is rendered for each cancer entity including the genes KRAS, EGFR and
TTF1, outlining the patients exceeding a user given threshold for the genes expression on the x-axis, with the expression level on the y-axis. This
plot is available in an entity (shown here) or a gene centric view. Further, Web-TCGA provides entity wise box plots (b), depicting an overview for
the expression status of a cancer entity and enabling the identification of the expression patterns per cancer entity
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variants of this class are not present in the queried en-
tities. Of great advantage, these graphs highlight that
structure-changing variants of TP53 and VHL are
highly associated with the BRCA and KIRC cancer
types. These results are in high concordance with a re-
cent study [9].
Visualization of global methylation profiling
To demonstrate the performance of Web-TCGA in
methylation profiling, we analyzed the methylation sta-
tus of SFRP1 and SFRP4 known to be highly differen-
tially methylated in colon adenocarcinoma (COAD) [10].
In the gene bodies we could confirm that in almost all
COAD samples SFRP1 but not SFRP4 was differentially
methylated compared to normal controls (see Fig. 2a).
For a more detailed illustration, Web-TCGA also
provides differential methylation histograms (Fig. 2b and c).
These histograms allow to estimate whether a gene is
more hyper-, hypo-methylated or both (for the latter
see Fig. 2c).
Visualization of global expression profiling
For illustration of global expression data Web-TCGA
provides an overview of the expression landscape of all
available tumor entities and genes. To take the quantita-
tive measure of expression data into account, Web-TCGA
provides waterfall diagrams and box plots for illustration
(Fig. 3a and b). In Fig. 3 we have chosen KRAS, EGFR and
TTF1 known to be frequently expressed in lung adenocar-
cinoma (LUAD). As expected more samples show an over
expression of these genes than an under expression.
Lung adenocarcinoma







































































Fig. 4 Illustration of CNV data. Just as for all other analyses types a global CNV profile is provided by Web-TCGA, as shown in a where the copy
number status for the genes FGFR1 and PIK3CA within the entities LUSC and LUAD is shown, giving a first overview of the CNV profile, which is
conducted of all samples harboring a gain or a loss. Furthermore, this profile can be created for all combinations of gains and losses alone, to
distinguish the proportions of low and high level gains and losses. To further resolve these global profiles, Web-TCGA provides bar plots, as
shown in b and c, for each entity chosen. These bar plots can be used to estimate the proportions of gains and losses within each entity in a
much finer grain as in (a)
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Visualization of CNVs
For handling CNV data GISTIC2.0 is used as basis.
Each gene in each sample is characterized by the copy
number variation value −2, −1, 0, 1 or 2, denoting
homozygous deletion, heterozygous deletion, normal
CN, low level and high level amplifications, respect-
ively. In the global CNV view (Fig. 4a), Web-TCGA
makes direct use of these categories and enables com-
parison of CNV status of all genes and entities. This
view can also be restricted to one of the CNV values
mentioned above. In the more detailed view, Web-
TCGA allows an illustration of the absolute number of
samples within each CNV value, for the genes and en-
tities to be analyzed (Fig. 4b and c). Here, we compared
the CNV categories of FGFR1 and PIK3CA in Lung
squamous cell carcinoma (LUSC) and Lung adenocar-
cinoma (LUAD). This comparison reflects the pub-
lished results [11], where PIK3CA is highly amplified in
more than 50 % of LUSC, but only in 4 % of LUAD.
Furthermore, FGFR1 is highly amplified in 72 % of all
LUSC, but only in a small subset of LUAD, and of these
with mainly low-level amplifications.
Conclusion
Compared to existing tools such as cBioPortal [12, 13]
and Firehose, Web-TCGA extends and complements
available functionality with its ability to display global
views that allow illustration and comparison of up to all
genes across up to all tumor entities. Furthermore, Web-
TCGA provides numerous more detailed views of molecu-
lar aberrations to facilitate in-depth analyses. Since these
views can be generated in a gene or entity centric way the
user can select to evaluate molecular aberrations of a
given gene in up to all cancer entities and vice versa.
Therefore Web-TCGA is a flexible and powerful open
source software which can be accessed over the internet
and can be installed on any computer. This software offers
researchers a fast, simple and integrative access to large-
scale studies of cancer genetics and provides features that
are complementary and supplement to existing tools such
as cBioPortal, Firebrowse and TCGA-Assembler. Similarly
to cBioPortal, due to the usage of high-level data, all func-
tionalities of Web-TCGA were implemented for real time
usage. Therefor a response within seconds is guarantied.
To gain a better understanding of Web-TCGAs function-
alities and underline its capabilities we provide more ex-
amples for each analysis type in the supplemental
material.
Availability and requirements
– Project name: Web-TCGA
– Project homepage: https://github.com/mariodeng/
web-TCGA
– Operating System: Platform independent
– Programming language: R 3.0.0
– Other requirements:
○ firehose_get
○ R packages: data.table, ggplot2 [14], markdown
– License: MIT
Additional file
Additional file 1: The supplemental material includes additional
examples and an introduction to the Web-TCGA user interface.
(DOCX 1522 kb)
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